You have 9 free searches left this month | for more free features.

Stage III

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Cancer Stage III Trial (Almonertinib)

Not yet recruiting
  • Lung Cancer Stage III
  • (no location specified)
Aug 8, 2023

Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

Not yet recruiting
  • Melanoma Stage III
  • Toripalimab combined with Temozolomide
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 23, 2023

Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +10 more
  • Discussion
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Mar 24, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Acute Side Effects In Stage III NSCLC With Definitive CRT

Completed
  • Non-small Cell Lung Cancer Stage III
    • Ankara, Turkey
      Ankara University Medicine School Radiation Oncology
    Aug 22, 2023

    Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

    Not yet recruiting
    • Papillary Renal Cell Carcinoma
    • (no location specified)
    Nov 24, 2023

    NSCLC Trial in Beijing

    Recruiting
    • NSCLC
      • Beijing, China
        Yuyan Wang
      Oct 10, 2023

      Lung Cancer Stage III Trial (ctDNA)

      Not yet recruiting
      • Lung Cancer Stage III
      • ctDNA
      • (no location specified)
      Oct 26, 2023

      Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant

      Completed
      • The Primary Study Metric is Progression-free Survival (PFS)
        • (no location specified)
        Jun 28, 2023

        Renal Cell Carcinoma Trial (Sunitinib)

        Not yet recruiting
        • Renal Cell Carcinoma
        • (no location specified)
        Sep 11, 2023

        Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

        Not yet recruiting
        • Stage III Non-small Cell Lung Cancer
        • (no location specified)
        Jun 3, 2023

        Stage III Vulvar Cancer, Stage III Ovarian Cancer, Stage III Uterine Cancer Trial in Indianapolis (Intervention group triads)

        Enrolling by invitation
        • Stage III Vulvar Cancer
        • +7 more
        • Intervention group triads
        • Indianapolis, Indiana
          Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
        Aug 10, 2023

        Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

        Not yet recruiting
        • Lung Cancer, Nonsmall Cell
        • Lung Cancer Stage III
        • Nivolumab and Chemotherapy
        • +3 more
        • (no location specified)
        Aug 15, 2023

        Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

        Not yet recruiting
        • Nasopharyngeal Carcinoma
        • without concurrent cisplatin chemotherapy
        • with concurrent cisplatin chemotherapy
        • Fuzhou, Fujian, China
          Department of radiation oncology, Fujian cancer hospital
        Oct 18, 2023

        NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

        Recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Sugemalimab and Chemotherapy
        • Changsha, China
          Hunan Cancer Hospital
        Jul 7, 2023

        Omitting Clinical Target Volume in Radical Treatment of

        Not yet recruiting
        • Immunotherapy
        • +3 more
        • IMRT+adjuvant immunotherapy
        • (no location specified)
        Jun 9, 2023

        Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

        Recruiting
        • Melanoma Stage III
        • North Sydney, New South Wales, Australia
          Melanoma Institute Australia
        Oct 26, 2022

        NSCLC Trial (Atezolizumab, Tiragolumab)

        Not yet recruiting
        • NSCLC
        • (no location specified)
        Apr 5, 2023

        Breast Cancer, Stage 0, Colorectal Cancer Stage I, Head Neck Cancer Stage I Trial (CaRE@Home intervention)

        Not yet recruiting
        • Breast Cancer, Stage 0
        • +11 more
        • CaRE@Home intervention
        • (no location specified)
        Jun 9, 2023

        Periodontitis Trial in Catania (Non-surgical periodontal treatment)

        Recruiting
        • Periodontitis
        • Non-surgical periodontal treatment
        • Catania, Italy
          AOU Policlinico G. Rodolico
        Aug 31, 2023

        Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

        Not yet recruiting
        • Ovarian Cancer
        • Birmingham, Alabama
          O'Neal Comprehensive Cancer Center at UAB
        Jul 18, 2023

        Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)

        Not yet recruiting
        • Colonic Neoplasms
        • Dostarlimab
        • +2 more
        • (no location specified)
        May 3, 2023

        NSCLC, Stage III Trial in Indianapolis (Signatera ctDNA test)

        Not yet recruiting
        • NSCLC, Stage III
        • Signatera ctDNA test
        • Indianapolis, Indiana
          Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
        Mar 13, 2023

        Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

        Recruiting
        • Advanced Colorectal Carcinoma
        • +15 more
        • Fermented Wheat Germ Extract
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Jul 26, 2023

        Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

        Not yet recruiting
        • Stage III NSCLC
        • Surgery
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Feb 21, 2023